140 related articles for article (PubMed ID: 15221967)
1. Oral lactoferrin inhibits growth of established tumors and potentiates conventional chemotherapy.
Varadhachary A; Wolf JS; Petrak K; O'Malley BW; Spadaro M; Curcio C; Forni G; Pericle F
Int J Cancer; 2004 Sep; 111(3):398-403. PubMed ID: 15221967
[TBL] [Abstract][Full Text] [Related]
2. Oral lactoferrin results in T cell-dependent tumor inhibition of head and neck squamous cell carcinoma in vivo.
Wolf JS; Li G; Varadhachary A; Petrak K; Schneyer M; Li D; Ongkasuwan J; Zhang X; Taylor RJ; Strome SE; O'Malley BW
Clin Cancer Res; 2007 Mar; 13(5):1601-10. PubMed ID: 17332307
[TBL] [Abstract][Full Text] [Related]
3. Fabrication of a Silk Sericin Hydrogel System Delivering Human Lactoferrin Using Genetically Engineered Silk with Improved Bioavailability to Alleviate Chemotherapy-Induced Immunosuppression.
Xu S; Tan H; Yang Q; Wang R; Tian C; Ji Y; Zhao P; Xia Q; Wang F
ACS Appl Mater Interfaces; 2021 Sep; 13(38):45175-45190. PubMed ID: 34525798
[TBL] [Abstract][Full Text] [Related]
4. Requirement for IFN-gamma, CD8+ T lymphocytes, and NKT cells in talactoferrin-induced inhibition of neu+ tumors.
Spadaro M; Curcio C; Varadhachary A; Cavallo F; Engelmayer J; Blezinger P; Pericle F; Forni G
Cancer Res; 2007 Jul; 67(13):6425-32. PubMed ID: 17616703
[TBL] [Abstract][Full Text] [Related]
5. Interleukin 2 gene transfer prevents NKG2D suppression and enhances antitumor efficacy in combination with cisplatin for head and neck squamous cell cancer.
Li D; Ronson B; Guo M; Liu S; Bishop JS; Van Echo DA; O'Malley BW
Cancer Res; 2002 Jul; 62(14):4023-8. PubMed ID: 12124336
[TBL] [Abstract][Full Text] [Related]
6. Enhanced antitumor efficacy of cisplatin in combination with ALRT1057 (9-cis retinoic acid) in human oral squamous carcinoma xenografts in nude mice.
Shalinsky DR; Bischoff ED; Gregory ML; Lamph WW; Heyman RA; Hayes JS; Thomazy V; Davies PJ
Clin Cancer Res; 1996 Mar; 2(3):511-20. PubMed ID: 9816198
[TBL] [Abstract][Full Text] [Related]
7. Synergistic in vivo antitumor effect of the histone deacetylase inhibitor MS-275 in combination with interleukin 2 in a murine model of renal cell carcinoma.
Kato Y; Yoshimura K; Shin T; Verheul H; Hammers H; Sanni TB; Salumbides BC; Van Erp K; Schulick R; Pili R
Clin Cancer Res; 2007 Aug; 13(15 Pt 1):4538-46. PubMed ID: 17671140
[TBL] [Abstract][Full Text] [Related]
8. Erythropoietin and Nrf2: key factors in the neuroprotection provided by apo-lactoferrin.
Zakharova ET; Sokolov AV; Pavlichenko NN; Kostevich VA; Abdurasulova IN; Chechushkov AV; Voynova IV; Elizarova AY; Kolmakov NN; Bass MG; Semak IV; Budevich AI; Kozhin PM; Zenkov NK; Klimenko VM; Kirik OV; Korzhevskii DE; Menshchikova EB; Vasilyev VB
Biometals; 2018 Jun; 31(3):425-443. PubMed ID: 29748743
[TBL] [Abstract][Full Text] [Related]
9. Interleukin-28B acts synergistically with cisplatin to suppress the growth of head and neck squamous cell carcinoma.
Yoshimoto K; Kishida T; Nakano H; Matsui M; Shin-Ya M; Shimada T; Nakai S; Imanishi J; Takeuchi M; Hisa Y; Mazda O
J Immunother; 2011 Mar; 34(2):139-48. PubMed ID: 21304406
[TBL] [Abstract][Full Text] [Related]
10. cis-Amminedichloro(2-methylpyridine) platinum(II) (AMD473), a novel sterically hindered platinum complex: in vivo activity, toxicology, and pharmacokinetics in mice.
Raynaud FI; Boxall FE; Goddard PM; Valenti M; Jones M; Murrer BA; Abrams M; Kelland LR
Clin Cancer Res; 1997 Nov; 3(11):2063-74. PubMed ID: 9815598
[TBL] [Abstract][Full Text] [Related]
11. Orally administered lactoferrin exerts an antimetastatic effect and enhances production of IL-18 in the intestinal epithelium.
Kuhara T; Iigo M; Itoh T; Ushida Y; Sekine K; Terada N; Okamura H; Tsuda H
Nutr Cancer; 2000; 38(2):192-9. PubMed ID: 11525597
[TBL] [Abstract][Full Text] [Related]
12. Lipid nanocarriers of a lipid-conjugated estrogenic derivative inhibit tumor growth and enhance cisplatin activity against triple-negative breast cancer: pharmacokinetic and efficacy evaluation.
Andey T; Sudhakar G; Marepally S; Patel A; Banerjee R; Singh M
Mol Pharm; 2015 Apr; 12(4):1105-20. PubMed ID: 25661724
[TBL] [Abstract][Full Text] [Related]
13. Recombinant Human Lactoferrin Augments Epirubicin Chemotherapy in Solid Ehrlich Carcinoma Bearing Mice.
El-Ashmawy NE; Khedr EG; El-Kady AY; Al-Ashmawy GM
Curr Drug Saf; 2023; 18(3):345-354. PubMed ID: 35507797
[TBL] [Abstract][Full Text] [Related]
14. 28-Day repeated dose oral toxicity of recombinant human apo-lactoferrin or recombinant human lysozyme in rats.
Cerven D; DeGeorge G; Bethell D
Regul Toxicol Pharmacol; 2008 Jul; 51(2):162-7. PubMed ID: 18457910
[TBL] [Abstract][Full Text] [Related]
15. Combined cetuximab and genistein treatment shows additive anti-cancer effect on oral squamous cell carcinoma.
Park SJ; Kim MJ; Kim YK; Kim SM; Park JY; Myoung H
Cancer Lett; 2010 Jun; 292(1):54-63. PubMed ID: 19959278
[TBL] [Abstract][Full Text] [Related]
16. Lactoferrin administration into the nostril alleviates murine allergic rhinitis and its mechanisms.
Wang SB; Deng YQ; Ren J; Xiao BK; Chen Z; Tao ZZ
Scand J Immunol; 2013 Dec; 78(6):507-15. PubMed ID: 24111738
[TBL] [Abstract][Full Text] [Related]
17. Lactoferrin inhibits growth of malignant tumors of the head and neck.
Wolf JS; Li D; Taylor RJ; O'Malley BW
ORL J Otorhinolaryngol Relat Spec; 2003; 65(5):245-9. PubMed ID: 14730178
[TBL] [Abstract][Full Text] [Related]
18. Consumption of transgenic milk containing the antimicrobials lactoferrin and lysozyme separately and in conjunction by 6-week-old pigs improves intestinal and systemic health.
Cooper CA; Maga EA; Murray JD
J Dairy Res; 2014 Feb; 81(1):30-7. PubMed ID: 24345426
[TBL] [Abstract][Full Text] [Related]
19. Synergistic activity of recombinant human endostatin in combination with adriamycin: analysis of in vitro activity on endothelial cells and in vivo tumor progression in an orthotopic murine mammary carcinoma model.
Plum SM; Hanson AD; Volker KM; Vu HA; Sim BK; Fogler WE; Fortier AH
Clin Cancer Res; 2003 Oct; 9(12):4619-26. PubMed ID: 14555538
[TBL] [Abstract][Full Text] [Related]
20. Rebamipide does not interfere with the antitumor effect of radiotherapy or chemotherapy in human oral tumor-bearing nude mice.
Shibamori M; Sato M; Uematsu N; Nakashima T; Sato A; Yamamura Y; Sasabe H; Umehara K; Sakurai K
J Pharmacol Sci; 2015 Sep; 129(1):18-25. PubMed ID: 26320673
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
